Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea · Delayed Price · Currency is KRW 5,870.00
+70.00 (1.21%)
At close: May 22, 2026
Seoulin Bioscience Market Cap
Seoulin Bioscience has a market cap or net worth of 51.75 billion as of May 22, 2026. Its market cap has decreased by -18.80% in one year.
Market Cap
51.75B
Enterprise Value
30.45B
Revenue
77.09B
Ranking
n/a
PE Ratio
106.73
Stock Price
5,870.00
Market Cap Chart
Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 51.75B, a decrease of -25.80%. That is a compound annual growth rate of -1.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 51.75B | -9.94% |
| Dec 30, 2025 | 57.46B | -6.51% |
| Dec 30, 2024 | 61.46B | -21.97% |
| Dec 28, 2023 | 78.77B | -19.25% |
| Dec 29, 2022 | 97.55B | -44.18% |
| Dec 30, 2021 | 174.75B | 62.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 328.26B |
| 3billion | 323.65B |
| GENINUS | 134.24B |
| GC Medical Science | 124.80B |
| Inventera | 123.96B |
| Cytogen | 110.73B |
| Protia | 60.72B |
| GeneMatrix | 41.40B |